82 results
Page 2 of 5
8-K
EX-99.1
uujgx
29 Apr 22
Clinical - Stage Biopharmaceutical Company Focused on Next Generation Therapeutics Meeting Unmet Patient Needs APRIL 2022
4:16pm
424B5
jn4my4np 43
13 Apr 22
Prospectus supplement for primary offering
5:18pm
424B5
ko41k9a1348j
11 Apr 22
Prospectus supplement for primary offering
5:31pm
8-K
EX-99.1
5yfp6zrz4o3
1 Sep 21
Clinical - Stage Biopharmaceutical Company Focused on Next Generation Therapeutics Meeting Unmet Patient Needs SEPTEMBER 2021
4:15pm
8-K
1a7ci
18 Jun 21
Other Events
12:00am
8-K
EX-99.1
j56h 2iz7956qjw17nj
24 May 21
Introduction to HT - KIT an mRNA Frame Shifting Therapeutic Significantly Inhibits Tumor Growth in Mast Cell - Derived Cancers
8:00am
8-K
EX-99.2
rjpwhvo64ivs i1xj
24 May 21
Introduction to HT - KIT an mRNA Frame Shifting Therapeutic Significantly Inhibits Tumor Growth in Mast Cell - Derived Cancers
8:00am
424B3
a7vlv4m6j tge6zhf
6 Apr 21
Prospectus supplement
6:07am
424B3
462ez47mowc 18n
19 Jan 21
Prospectus supplement
4:23pm
8-K
EX-99.1
4ycc4m2dplwc4ssty3
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
27kr9xqm
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.1
gpaqb 7wvq
31 Aug 20
Hoth Therapeutics Appoints Dr. Stefanie Johns, Ph.D., as Chief Scientific Officer
4:25pm